| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/06/1999 | US5919456 IL-13 receptor specific chimeric proteins |
| 07/06/1999 | US5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 07/06/1999 | US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/06/1999 | US5919452 Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies |
| 07/06/1999 | US5919450 Glutathione S-transferase homolog |
| 07/06/1999 | US5919445 Use of green fluorescent protein to trace the infection of baculovirus in insects and to increase viral UV stability |
| 07/06/1999 | US5919444 Method for decreasing severity of acute and chronic pancreatitis |
| 07/06/1999 | CA2233593A1 Novel protein molecules and uses therefor |
| 07/06/1999 | CA2182521C Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA2086417C Melanin production by transformed organisms |
| 07/06/1999 | CA2058785C Method of producing proteins with fviii activity and/or fviii derivatives |
| 07/06/1999 | CA2004764C Ancrod proteins, their preparation and use |
| 07/06/1999 | CA2000604C Process for the activation of genetechnologically produced, biologically-active proteins expressed in prokaryotes |
| 07/06/1999 | CA1340639C Mutant acidic fibroblast growth factor |
| 07/06/1999 | CA1340636C Dermorphin analogs, their methods of preparation, pharmaceutical compositions and methods of therapeutic treatment using the same |
| 07/06/1999 | CA1340629C T-cell receptor gene located within alpha locus and dna constructions |
| 07/06/1999 | CA1340627C T4 glycoprotien fragments and use of fragments of t4 in the treatment of aids |
| 07/06/1999 | CA1340625C Cloned cardionatrin cdna |
| 07/06/1999 | CA1340624C Modified vaccinia virus and methods for making and using the same |
| 07/05/1999 | WO1999038976A2 Human growth factor homologs |
| 07/05/1999 | CA2317812A1 Human growth factor homologs |
| 07/01/1999 | WO1999032657A1 Staphylococcus aureus histidine protein kinase essential genes |
| 07/01/1999 | WO1999032648A1 Recombinant rhabdovirus containing a heterologous fusion protein |
| 07/01/1999 | WO1999032644A2 Prostate cancer gene |
| 07/01/1999 | WO1999032643A2 Mood disorder gene |
| 07/01/1999 | WO1999032640A1 Antagonists of g-protein-coupled receptor |
| 07/01/1999 | WO1999032639A1 Receptor tyrosine kinase, ar-1, is a regulator of angiogenesis |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032633A1 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof |
| 07/01/1999 | WO1999032632A1 Novel embryo-derived interleukin related factor molecules and uses therefor |
| 07/01/1999 | WO1999032631A1 CHEMOKINE OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN |
| 07/01/1999 | WO1999032629A1 Tigirr dna and polypeptides |
| 07/01/1999 | WO1999032628A2 Wip, a wasp-associated protein |
| 07/01/1999 | WO1999032627A2 The protein tyrosine kinase substrate lat and its use in the identification of (ant)agonists of the kinase |
| 07/01/1999 | WO1999032626A1 Sigirr dna and polypeptides |
| 07/01/1999 | WO1999032625A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/01/1999 | WO1999032624A1 Human proteins responsible for nedd8 activation and conjugation |
| 07/01/1999 | WO1999032623A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 07/01/1999 | WO1999032622A2 Semaphorin zsmf-3 |
| 07/01/1999 | WO1999032621A2 Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032615A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 07/01/1999 | WO1999032614A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | WO1999032609A1 Molecules associated with the human fused gene |
| 07/01/1999 | WO1999032608A1 MULTIPLE DRUG RESISTANCE GENE atrD OF $i(ASPERGILLUS NIDULANS) |
| 07/01/1999 | WO1999032603A1 Bacterial nitrite oxidizer and method of use thereof |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032519A1 Novel g protein-coupled receptor |
| 07/01/1999 | WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | WO1999032517A1 Molecules associated with the human suppressor of fused gene |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999032515A2 Angiopoietin homolog, dna encoding it, and method of making it |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032513A1 Protein binding polypeptides |
| 07/01/1999 | WO1999032505A1 MULTIPLE DRUG RESISTANCE GENE atrC OF $i(ASPERGILLUS NIDULANS) |
| 07/01/1999 | WO1999032502A1 Pdzk1 protein containing pdz interaction domains |
| 07/01/1999 | WO1999032459A1 Chymase inhibitors |
| 07/01/1999 | WO1999032428A2 Synthesis of diamines |
| 07/01/1999 | WO1999032149A1 GENES FOR MALE ACCESSORY GLAND PROTEINS IN $i(DROSOPHILA MELANOGASTER) |
| 07/01/1999 | WO1999032147A1 Immunization for ebola virus infection |
| 07/01/1999 | WO1999032143A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
| 07/01/1999 | WO1999032142A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | WO1999032141A1 Ifnar2/ifn complex |
| 07/01/1999 | WO1999032140A1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 07/01/1999 | WO1999032137A1 Lymphotactin as an adjuvant |
| 07/01/1999 | WO1999032136A1 Chimeric proteins for the treatment of diabetes |
| 07/01/1999 | WO1999032135A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | WO1999032134A1 Substantially pure histidine-linked protein polymer conjugates |
| 07/01/1999 | WO1999032133A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections |
| 07/01/1999 | WO1999031990A1 Carbohydrate oxidase and use thereof in baking |
| 07/01/1999 | WO1999031982A1 Transvascular delivery of a composition to an extravascular tissue of a mammal |
| 07/01/1999 | WO1999031964A1 Nucleotide polymorphisms in soybean |
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | WO1999020121A3 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 07/01/1999 | WO1999019491A3 Human dnax interleukin-40 (dil-40) |
| 07/01/1999 | WO1999019470A3 Gfp-annexin fusion proteins |
| 07/01/1999 | WO1999018909A9 Interferon-gamma regulatory factors |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | WO1999012962A8 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 07/01/1999 | WO1999010487A3 Novel transcriptional regulators and uses therefor |
| 07/01/1999 | WO1999010014A3 Receptor-mediated gene delivery using bacteriophage vectors |
| 07/01/1999 | DE19757695A1 Klonierte, Neurotransmitter-Rezeptor produzierende Zellen Cloned, neurotransmitter receptor-producing cells |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | CA2318434A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
| 07/01/1999 | CA2318355A1 Chimeric proteins for the treatment of diabetes |
| 07/01/1999 | CA2316769A1 The protein tyrosine kinase substrate lat and its use in the identification of (ant)agonists of the kinase |
| 07/01/1999 | CA2316323A1 Lymphotactin as an adjuvant |
| 07/01/1999 | CA2316081A1 Bacterial nitrite oxidizer and method of use thereof |
| 07/01/1999 | CA2316034A1 Sigirr dna and polypeptides |
| 07/01/1999 | CA2316015A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315943A1 Multiple drug resistance gene atrc of aspergillus nidulans |
| 07/01/1999 | CA2315942A1 Tigirr dna and polypeptides |
| 07/01/1999 | CA2315888A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | CA2315644A1 Antagonists of g-protein-coupled receptor |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315301A1 Protein binding polypeptides |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315245A1 Secreted proteins and polynucleotides encoding them |